Canntab Therapeutics Limited

CNSX:PILL Stock Report

Market Cap: CA$194.5k

Canntab Therapeutics Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Richard Goldstein

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.1yrs
CEO ownershipn/a
Management average tenure5.7yrs
Board average tenure6.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Richard Goldstein's remuneration changed compared to Canntab Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Feb 28 2023n/an/a

-CA$3m

Nov 30 2022n/an/a

-CA$3m

Aug 31 2022n/an/a

-CA$4m

May 31 2022n/an/a

-CA$4m

Feb 28 2022n/an/a

-CA$5m

Nov 30 2021n/an/a

-CA$5m

Aug 31 2021n/an/a

-CA$4m

May 31 2021n/an/a

-CA$4m

Feb 28 2021n/an/a

-CA$3m

Nov 30 2020n/an/a

-CA$3m

Aug 31 2020n/an/a

-CA$3m

May 31 2020CA$130kCA$120k

-CA$3m

Feb 29 2020n/an/a

-CA$2m

Nov 30 2019n/an/a

-CA$2m

Aug 31 2019n/an/a

-CA$2m

May 31 2019CA$138kCA$120k

-CA$2m

Feb 28 2019n/an/a

-CA$4m

Nov 30 2018n/an/a

-CA$3m

Aug 31 2018n/an/a

-CA$3m

May 31 2018n/an/a

-CA$2m

Feb 28 2018n/an/a

-CA$1m

Nov 30 2017n/an/a

-CA$2m

Aug 31 2017n/an/a

-CA$1m

May 31 2017CA$154kCA$20k

-CA$1m

Compensation vs Market: Insufficient data to establish whether Richard's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.

CEO

Richard Goldstein (62 yo)

6.1yrs

Tenure

CA$129,600

Compensation

Mr. Richard C. Goldstein is the Co-founder of Canntab Therapeutics Limited and serves as Interim Chief Executive Office from July 31, 2022. He serves as Chief Financial Officer of Canntab Therapeutics Limi...

Leadership Team

NamePositionTenureCompensationOwnership
Richard Goldstein
Interim CEO6.1yrsCA$129.60kno data
Barry Polisuk
Secretary & Independent Director6.1yrsCA$62.28kno data
Joshi Laxminarayan
Chief Scientific Officer4yrsno datano data
Eric Malinski
Director of Marketing5.3yrsno datano data

5.7yrs

Average Tenure

Experienced Management: PILL's management team is seasoned and experienced (5.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Richard Goldstein
Interim CEO6.1yrsCA$129.60kno data
Barry Polisuk
Secretary & Independent Director6.1yrsCA$62.28kno data
Lorne Gertner
Member of Advisory Boardno datano datano data
Vitor Fonseca
Independent Director6.1yrsno datano data
Hugh Sutherland
Member of Advisory Boardno datano datano data
Bob Woloschuk
Member of Advisory Board6yrsno datano data
Sabrina Ramkellawan
Member of Advisory Boardno datano datano data
Eric Hatashita
Member of Advisory Boardno datano datano data

6.1yrs

Average Tenure

65yo

Average Age

Experienced Board: PILL's board of directors are considered experienced (6.1 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.